Skip to content

Evaluation of the Hemodynamic Effects of Ciprofol Combined with Alfentanil in Patients Undergoing Painless Gastroenteroscopy via Echocardiography

Evaluation of the Hemodynamic Effects of Ciprofol Combined with Alfentanil in Patients Undergoing Painless Gastroenteroscopy via Echocardiography

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500114401
Enrollment
Unknown
Registered
2025-12-11
Start date
2025-12-15
Completion date
Unknown
Last updated
2025-12-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Painless Gastrointestinal Endoscopy

Interventions

Experimental group:an initial dose of alfentanil ((7 µg/kg ) and ciprofol (0.4 mg/kg ) for the induction of sedation.Maintenance dose of sedation was by bolus top-ups (0.2 mg/kg for ciprofol).
control group:an initial dose of alfentanil ((7 µg/kg ) and propofol (1.5 mg/kg ) for the induction of sedation.Maintenance dose of sedation was by bolus top-ups (0.5 mg/kg for propofol).

Sponsors

Chongqing Red Cross Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 74 Years

Inclusion criteria

Inclusion criteria: 1.Patients undergoing elective painless gastroenteroscopy at Chongqing Red Cross Hospital; 2.Aged 18–74 years, with a BMI of 18.5–30 kg/m² and an ASA physical status classification of ?–?;

Exclusion criteria

Exclusion criteria: 1.Myocardial infarction or unstable angina within 6 months; 2.Third-degree atrioventricular block; 3.Severe snoring; 4.Obstructive sleep apnea syndrome (OSAS); 5.Dialysis treatment; 6.Psychiatric/mental disorders or cognitive impairment; 7.History of abuse of psychotropic drugs or anesthetics; 8.Pregnant or lactating women; 9.Allergies or contraindications to the drugs used.

Design outcomes

Primary

MeasureTime frame
mitral annular plane systolic excursion;cardiac index;stroke volume index;systemic vascular resistance index;Mean Arterial Pressure(MAP);

Secondary

MeasureTime frame
Heart Rate (HR);Pulse Oximetry (SpO?);

Countries

China

Contacts

Public ContactPeng Ji

Chongqing Red Cross Hospital

705621348@qq.com+86 159 2250 3674

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026